Inducible Nitric Oxide Synthase and Its Product Nitric Oxide, a Small Molecule with Complex Biological Activities

Biological Chemistry Hoppe-Seyler

Volumn 376, Issue 6, 1995, Pages 327-356

  Kroncke, Klaus D ^a   Fehsel, Karin ^a   Kolb Bachofen, Victoria ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Arginine; Cytokines; Diseases; Immune regulation; NO Donors

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL; BIOSYNTHESIS; CHEMISTRY; ENZYME INDUCTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW;

ANIMAL; ENZYME INDUCTION; HUMAN; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE;

EID: 0029310567     PISSN: 01773593     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/bchm3.1995.376.6.327     Document Type: Review

References (96)

1. Albini, A., Melchiori, A., Santi, L., Liotta L.A., Brown, P.D., and Stetler Stevenson, W.G. (1991). Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83,775-779.
2. Alvarez, O.A., Carmichael, D.F., and DeClerck, Y.A. (1990). Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82,589-595.
3. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H.J., and Herrlich, P. (1987a). 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5-flanking region. Mol. Cell Biol. 7,2256-2266. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P., and Karin, M. (1987b). Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729–739.
4. Auble, D.T., and Brinckerhoff, C.E. (1991). The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30,4629-4635.
5. Bernhard, E.J., Gruber, S.B., and Muschel, R.J. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA 91, 4293–4297.
6. Birkedal-Hansen, H. (1993). Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64,474-484.
7. Borregaard, N., Sehested, M., Nielsen, B.S., Sengelov, H., and Kjeldsen, L. (1995). Biosynthesis o granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85,812-817.
8. Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M. (1989). Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337,661 -663.
9. Brinckerhoff, C.E. (1992). Regulation of metalloproteinase gene expression: implications for osteoarthritis. Crit. Rev. Eukaryot. Gene Expr. 2,145-164.
10. Buttice, G., Quinones, S., and Kurkinen, M. (1991). The AP-1 site is required for basal expression but is not necessary forTPA-re-sponse of the human stromelysin gene. Nucleic. Acids. Res. 19,3723-3731.
11. Chiu, R., Angel, P., and Karin, M. (1989). Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59,979-986.
12. Collier, I.E., Wilhelm, S.M., Eisen, A.Z., Marmer, B.L., Grant, G.A., Seltzer, J.L., Kronberger, A., He, C.S., Bauer, E.A., and Goldberg, G.I. (1988). H-ras oncongene-transformed human bronchial epithelial cells (TBE-1) secrete a single metallo-protease capable of degrading basement membrane collagen. J. Biol. Chem. 263,6579-6587.
13. Corcoran, M.L., Stetler Stevenson, W.G., Brown, P.D., and Wahl, L.M. (1992). Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267,515-519.
14. Cross, J.C., Werb, Z., and Fisher, S.J. (1994). Implantation and the placenta: Key pieces of the development puzzle. Science 266, 1508–1518.
15. Dayer, J.M., de Rochemonteix, B., Burrus, B., Demczuk, S., and Dinarello, C.A. (1986). Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J. Clin. Invest. 77,645-648.
16. De Clerck, Y.A., Darville, M.I., Eeckhout, Y., and Rousseau, G.G. (1994). Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139,185-191.
17. Delany, A.M., and Brinckerhoff, C.E. (1992). Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J. Cell Biochem. 50,400-410.
18. Dittmann, K.H., and Petrides, P.E. (1991). A 41 kDa transferrin related molecule acts as an autocrine growth factor for HL-60 cells. Biochem. Biophys. Res. Commun. 176,473-478.
19. Dittmann, K.H., Lottspeich, F., Ries, C., and Petrides, P.E. (1995). Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Exp. Hematol. 23, 155–160. Edwards, D.R., Murphy, G., Reynolds, J.J., Whitham, S.E., Docherty, A.J., Angel, P. and Heath, J.K. (1987). Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6,1899-1904.
20. Edwards, D.R., Rochelau, H., Sharma, R.R., Wills, A.J., Cowie, A., Hassel, J.A., and Heath, J.K. (1992). Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1171,41-55.
21. Emonard, H., and Grimaud, J.A. (1990). Matrix metalloproteinases. A review. Cell Mol. Biol. 36,131-153.
22. Everts, V., Delaisse, J.M., Korper, W., Niehof, A., Vaes, G., and Beertsen, W. (1992). Degradation of collagen in the bone-re-sorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.
23. Freije, J.M., Diez Itza, I., Balbin, M., Sanchez, L.M., Blasco, R.,To-livia, J., and Lopez Otin, C. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metallo-proteinase produced by breast carcinomas. J. Biol. Chem. 269,16766-16773.
24. Frisch, S.M., and Morisaki, J.H. (1990). Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell Biol. 10,6524-6532.
25. Frisch, S.M., and Ruley, H.E. (1987). Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J. Biol. Chem. 262,16300-16304.
26. Goldberg, G.I., Marmer, B.L., Grant, G.A., Eisen, A.Z., Wilhelm, S., and He, C.S. (1989). Human 72-kDa type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86,8207-8211.
27. Gutman, A., and Wasylyk, B. (1990). The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9,2241 -2246.
28. Hibbs, M.S. (1992). Expression of 92 kDa phagocyte gelatinase by inflammatory and connective tissue cells. In: Matrix Metalloproteinases and Inhibitors. H. Birkedal-Hansen, Z., Werb, H., Welgus, and H. Van Wart, eds. (Stuttgart; New York: Gustav Fischer Verlag), pp. 52–57.
29. Ito, A., Sato, T., Iga, T., and Mori, Y. (1990). Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts [published erratum appears in FEBS Lett 1990 Oct; 271 (1-2): 258]. FEBS Lett. 269,93-95.
30. Jeffrey, J.J. (1991). Collagen and collagenase: pregnancy and parturition. Semin. Perinatol. 15,118-126.
31. Jeffrey, J.J. (1992). Collagen degradation. In: Wound Healing: Biochemical and Clinical Aspects. R.F. Diegelmann and W.J. Lindblad, eds. (Philadelphia, PA: W.B. Saunders Company), pp. 177–194.
32. Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H., and Herrlich, P. (1990). Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62,1189-1204.
33. Juliano, R.L., and Haskill, S. (1993). Signal transduction from the extracellular matrix. J. Cell Biol. 120,577-585.
34. Kellerer, M., Obermaier, Kusser, B., Ermel, B., Wallner, U., Haring, H.U., and Petrides, P.E. (1990). An altered IGF-I receptor is present in human leukemic cells. J. Biol. Chem. 265,9340-9345.
35. Kerr, L.D., Holt, J.T., and Matrisian, L.M. (1988a). Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242,1424-1427.
36. Kerr, L.D., Olashaw, N.E., and Matrisian, L.M. (1988b).Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J. Biol. Chem. 263,16999-17005. Kerr, L.D., Miller, D.B., and Matrisian, L.M. (1990).TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61, 267–278.
37. Keski Oja, J., Koli, K., Lohi, J., and Laiho, M. (1991). Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Semin. Thromb. Hemost. 17,231-239.
38. Khokha, R., Waterhouse, P., Yagel, S., Lala, P.K., Overall, C.M., Norton, G., and Denhardt, D.T. (1989). Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243,947-950.
39. Krane, S.M. (1993). Some molecular mechanisms of glucocorticoid action. Br. J. Rheumatol. 32 Suppl2,3-5.
40. Kurzrock, R., Kantarjian, H., Wetzler, M., Estrov, Z., Estey, E., Troutman Worden, K., Gutterman, J.U., and Talpaz, M. (1993). Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage. Exp. Hematol. 21,80-85.
41. Lacraz, S., Nicod, L., Galve de Rochemonteix, B., Baumberger, C., Dayer, J.M., and Welgus, H.G. (1992). Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90,382-388.
42. Lafyatis, R., Kim, S.J., Angel, P., Roberts, A.B., Sporn, M.B., Karin, M., and Wilder, R.L. (1990). Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5 activator protein-1 -binding site. Mol. Endocrinol. 4,973-980.
43. Laiho, M., Saksela, O., and Keski Oja, J. (1987). Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J. Biol. Chem. 262,17467-17474.
44. Liotta, L.A., Steeg, P.S., and Stetler Stevenson, W.G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64,327-336.
45. Lyons, J.G., Birkedal Hansen, B., Pierson, M.C., Whitelock, J.M., and Birkedal Hansen, H. (1993). Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratino-cytes. J. Biol. Chem. 268,19143-19151.
46. Machida, C.M., Muldoon, L.L., Rodland, K.D., and Magun, B.E. (1988). Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta. Mol. Cell Biol. 8,2479-2483.
47. Mackay, A.R., Ballin, M., Pelina, M.D., Farina, A.R., Nason, A.M., Hartzler, J.L., and Thorgeirsson, U.P. (1992). Effect of phorbol ester and cytokines on matrix metalloproteinase expression in tumor and normal cell lines. Invas. Metast. 12,168-184.
48. MacNaul, K.L., Chartrain, N., Lark, M., Tocci, M.J., and Hutchinson, N.I. (1990). Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265,17238-17245.
49. Martel Pelletier, J., Zafarullah, M., Kodama, S., and Pelletier, J.P. (1991). In vitro effects of interleukin 1 on the synthesis of metal-loproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J. Rheumatol. Suppl. 27,80-84.
50. Masure, S., Proost, P., van Damme, J., and Opdenakker, G. (1991). Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198,391-398.
51. Matrisian, L.M. (1992a). The matrix-degrading metalloproteinases. Bioessays 14,455-463.
52. Matrisian, L.M., Ganser, G.L., Kerr, L.D., Pelton, R.W., and Wood, L.D. (1992b). Negative regulation of gene expression by TGF-beta. Mol. Reprod. Dev. 32,111-120.
53. Mauviel, A. (1993). Cytokine regulation of metalloproteinase gene expression. J. Cell Biochem. 53,288-295.
54. Mauviel, A., Kahari, V.M., Evans, C.H., and Uitto, J. (1992a). Transcriptional activation of fibroblast collagenase gene expression by a novel lymphokine, leukoregulin. J. Biol. Chem. 267, 5644- 5648.
55. Mauviel, A., Kahari, V.M., Kurkinen, M., Evans, C.H., and Uitto, J. (1992b). Leukoregulin, a T-cell derived cytokine, up-regulates stromelysin-1 gene expression in human dermal fibroblasts: Evidence for the role of AP-1 in transcriptional activation. J. Cell Biochem. 50,53-61.
56. Mignatti, P., and Rifkin, D.B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73,161-195.
57. Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. (1993). A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362,839-841.
58. Mohtai, M., Smith, R.L., Schurman, D.J., Tsuji, Y., Torti, F.M., Hutchinson, N.I., Stetler Stevenson, W.G., and Goldberg, G.I. (1993). Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J. Clin. Invest. 92,179-185.
59. Morodomi.T., Ogata, Y., Sasaguri, Y., Morimatsu, M., and Nagase, H. (1992). Purification and characterization of matrix metallo-proteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J. 285,603-611.
60. Nagase, H., Ogata, Y., Suzuki, K., Enghild, J.J., and Salvesen, G. (1991). Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem. Soc. Trans. 19,715-718.
61. Nakamura, T., Ebihara, I., Osada, S.,Takahashi, T., Yamamoto, M., Tomino, Y., and Koide, H. (1993). Gene expression of metallo-proteinases and their inhibitor in renal tissue of New Zealand Black/White F1 mice. Clin. Sci. 85,295-301.
62. Nathan, C., and Sporn, M. (1991). Cytokines in context. J. Cell Biol. 113,981-986.
63. Nerlov, C., Rorth, P., Blasi, F., and Johnsen, M. (1991). Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6,1583-1592.
64. Nicholson, R.C., Mader, S., Nagpal, S., Leid, M., Rochette Egly, C., and Chambon, P. (1990). Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9,4443-4454.
65. Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H. (1990). Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721–730.
66. Overall, C.M., Wrana, J.L., and Sodek, J. (1991). Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266,14064-14071.
67. Pan, L., Chamberlain, S.H., Auble, D.T., and Brinckerhoff, C.E. (1992). Differential regulation of collagenase gene expression by retinoic acid receptors-alpha, beta and gamma. Nucleic. Acids. Res. 20,3105-3111.
68. Petrides, P.E., and Dittmann, K.H. (1990). How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles. Ann. Hematol. (Blut) 67,3-13.
69. Rechberger, T., and Woessner, J.F.J. (1993). Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am. J. Obstet. Gynecol. 168,1598-1603.
70. Ries, C., Kolb, H„ and Petrides, P.E. (1994). Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis fac- tor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83,3638-3646.
71. Saarialho Kere, U.K., Chang, E.S., Welgus, H.G., and Parks, W.C. (1993). Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J. Invest. Dermatol. 100,335-342.
72. Salo.T., Lyons, J.G., Rahemtulla, F., Birkedal Hansen, H., and Lar-java, H. (1991). Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem. 266,11436-11441.
73. Sato, H., and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8,395-405.
74. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. (1992). Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7, 77–83.
75. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 370,61-65.
76. Schonthal, A., Herrlich, P., Rahmsdorf, H.J., and Ponta, H. (1988). Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54,325-334.
77. Schultz, G.S., Strelow, S., Stern, A., Chegini, N., Grant, M.B., Galardy, R.E., Grobelny, D., Rowsey, J.J., Stonecipher, K., Parmley, V., and Khaw, P.T. (1992). Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest. Ophthalmol. Visual. Sci. 33,3325-3331.
78. Schultz, R.M., Silberman, S., Persky, B., Bajkowski, A.S., and Carmichael, D.F. (1988). Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48,5539-5545.
79. Shapiro, S.D., Kobayashi, D.K., Pentland, A.P., and Welgus, H.G. (1993). Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268, 8170–8175.
80. Stetler-Stevenson, W.G., Liotta, L.A., and Kleiner, D.E.J. (1993a). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7,1434-1441.
81. Stetler-Stevenson, W.G., Aznavoorian, S., and Liotta, L.A. (1993b). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9,541 -473.
82. Takahashi, S., Sato, T., Ito, A., Ojima, Y., Hosono, T., Nagase, H., and Mori, Y. (1993). Involvement of protein kinase C in the interleukin 1 alpha-induced gene expression of matrix metallo-proteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts. Biochim. Biophys. Acta 1220,57-65.
83. Talhouk, R.S., Bissel, M.J., and Werb, Z. (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118,1271-1282.
84. Timpl, R. (1989). Structure and biological activity of basement membrane proteins. Eur. J. Biochem. 180,487-502.
85. Tremble, P.M., Lane, T.F., Sage, E.H., and Werb, Z. (1993). SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent path-way. J. Cell Biol. 121,1433-1444.
86. Twining, S.S. (1994). Regulation of proteolytic activity in tissues. Crit. Rev. Biochem. Mol. 29(5), 315–383.
87. Unemori, E.N., Hibbs, M.S., and Amento, E.P. (1991). Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88,1656-1662.
88. Vine, N., and Powell, J.T. (1991). Metalloproteinases in degenerative aortic disease. Clin. Sci. 81,233-239.
89. Vogt, P.K., and Bos, T.J. (1990). jun: oncogene and transcription factor. Adv. Cancer Res. 55,1 -35.
90. Wahl, L.M., and Corcoran, M.L. (1993). Regulation of monocyte/ macrophage metalloproteinase production by cytokines. J. Periodontol. 64,467-473.
91. Wasylyk, C., Gutman, A., Nicholson, R., and Wasylyk, B. (1991). The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO. J. 10,1127-1134.
92. Weber, H.F., Vogt, G., Pruett, R.C., Stöhr, H., and Felbor, U. (1994). Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nature Genetics 8,352-355. Wilhelm, S.M., Collier, I.E., Marmer, B.L., Eisen, A.Z., Grant, G.A., and Goldberg, G.I. (1989). SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264,17213-17221.
93. Wilkinson, D.G., Bhatt, S., Ryseck, R.P., and Bravo, R. (1989). Tis-suespecific expression of c-jun and junB during organogenesis in the mouse. Development 106,465-471.
94. Woessner, J.F., Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145–2154.
95. Woessner, J.F., Jr. (1992). Role of cellular proteinases and their protein inhibitors in inflammation. In: Immunology and Medicine, Biochemistry of Inflammation. J.T. Whicher and J.F.J. Woessner, eds. (Dordrecht, The Netherlands: Kluwer Academic Publishers), pp. 57–89.
96. Woessner, J.F., Jr. (1994). The family of matrix metalloproteinases. Ann. N.Y. Acad. Sci. 732,11-21.